BlackRock Fund Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

BlackRock Fund Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$112M	Buy	4,444,772 +492,424	+12%	+$11M	0.02%	1111
2016 Q3	$97.7M	Buy	3,952,348 +853,080	+28%	+$19.3M	0.02%	1086
2016 Q2	$63.1M	Buy	3,099,268 +272,279	+10%	+$4.83M	0.01%	1335
2016 Q1	$43.1M	Buy	2,826,989 +31,238	+1%	+$408K	0.01%	1545
2015 Q4	$37.6M	Sell	2,795,751 -17,857	-0.6%	-$276K	0.01%	1669
2015 Q3	$39.5M	Buy	2,813,608 +330,918	+13%	+$6.15M	0.01%	1576
2015 Q2	$42.2M	Buy	2,482,690 +1,125,874	+83%	+$16M	0.01%	1636
2015 Q1	$16.4M	Buy	1,356,816 +22,301	+2%	+$211K	﹤0.01%	2171
2014 Q4	$11.1M	Buy	1,334,515 +120,602	+10%	+$1.01M	﹤0.01%	2403
2014 Q3	$10.5M	Buy	1,213,913 +8,513	+0.7%	+$76.9K	﹤0.01%	2314
2014 Q2	$13.2M	Buy	1,205,400 +229,881	+24%	+$2.05M	﹤0.01%	2249
2014 Q1	$8.72M	Buy	975,519 +151,886	+18%	+$1.4M	﹤0.01%	2476
2013 Q4	$6.21M	Buy	823,633 +70,057	+9%	+$490K	﹤0.01%	2675
2013 Q3	$5.52M	Buy	753,576 +98,929	+15%	+$664K	﹤0.01%	2742
2013 Q2	$4.21M	Buy	+654,647	New	+$3.86M	﹤0.01%	2804

Other funds holding SUPN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RCAMU

Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

BlackRock Fund Advisors's SUPN Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Supernus Pharmaceuticals (SUPN) stake by 12% in Q4 2016, buying an estimated $11M and bringing the position to 4,444,772 shares worth $112M. The position accounts for 0.02% of the portfolio, ranked #1111.

BlackRock Fund Advisors first reported a position in SUPN in Q2 2013 and has held it in 15 quarters since. 233 funds tracked by Wall St. Rank hold SUPN as of Q4 2016.

BlackRock Fund Advisors held 4,444,772 shares of Supernus Pharmaceuticals worth $112M as of Q4 2016.
BlackRock Fund Advisors bought 492,424 Supernus Pharmaceuticals shares in Q4 2016, an estimated $11M.
Supernus Pharmaceuticals made up 0.02% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1111 holding.
BlackRock Fund Advisors first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
233 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.